Fatigue in primary biliary cirrhosis

被引:50
作者
Abbas, Ghulam [1 ]
Jorgensen, Roberta A. [1 ]
Lindor, Keith D. [1 ]
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
关键词
QUALITY-OF-LIFE; CHOLESTASIS-ASSOCIATED FATIGUE; URSODEOXYCHOLIC ACID THERAPY; CONTROLLED-TRIAL; AUTONOMIC DYSFUNCTION; NEUROACTIVE STEROIDS; SYMPTOM PROGRESSION; DAYTIME SOMNOLENCE; NATURAL-HISTORY; SEVERITY SCALE;
D O I
10.1038/nrgastro.2010.62
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Primary biliary cirrhosis (PBC) is a chronic, autoimmune, cholestatic liver disease with a slowly progressive course. Without treatment, most patients eventually develop fibrosis of the liver and may need liver transplantation in the late stage of disease. Fatigue and pruritus are the most common symptoms of PBC, but the majority of patients are asymptomatic at first presentation. There is no specific treatment for fatigue in PBC, but modafinil has shown some potential beneficial effects, such as increased energy levels and decreased total sleep time. This Review article discusses the natural history and the measurement of fatigue in patients with PBC. The central and the peripheral mechanisms that have been suggested for the pathogenesis of fatigue in PBC are also discussed and treatment options are reviewed.
引用
收藏
页码:313 / 319
页数:7
相关论文
共 80 条
[1]
Neuroactive steroids and fatigue severity in patients with primary biliary cirrhosis and hepatitis C [J].
Ahboucha, S. ;
Butterworth, R. F. ;
Pomier-Layrargues, G. ;
Vincent, C. ;
Hassoun, Z. ;
Baker, G. B. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2008, 20 (06) :671-679
[2]
Reduced plasma dehydroepiandrosterone sulfate levels are significantly correlated with fatigue severity in patients with primary biliary cirrhosis [J].
Ahboucha, Samir ;
Pomier-Layrargues, Gilles ;
Vincent, Catherine ;
Hassoun, Ziad ;
Tamaz, Raja ;
Baker, Glen ;
Butterworth, Roger F. .
NEUROCHEMISTRY INTERNATIONAL, 2008, 52 (4-5) :569-574
[3]
Locomotor muscle fatigue modifies central motor drive in healthy humans and imposes a limitation to exercise performance [J].
Amann, Markus ;
Dempsey, Jerome A. .
JOURNAL OF PHYSIOLOGY-LONDON, 2008, 586 (01) :161-173
[4]
Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy [J].
Babatin, M. A. ;
Sanai, F. M. ;
Swain, M. G. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (05) :813-820
[5]
Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients [J].
Battezzati, PM ;
Zuin, M ;
Crosignani, A ;
Allocca, M ;
Invernizzi, P ;
Selmi, C ;
Villa, E ;
Podda, M .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (09) :1427-1434
[6]
Circulating acute phase mediators and skeletal muscle performance in hospitalized geriatric patients [J].
Bautmans, I ;
Njemini, R ;
Lambert, M ;
Demanet, C ;
Mets, T .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2005, 60 (03) :361-367
[7]
The pruritus of cholestasis [J].
Bergasa, NV .
JOURNAL OF HEPATOLOGY, 2005, 43 (06) :1078-1088
[8]
Primary biliary cirrhosis: Report of a focus study group [J].
Bergasa, NV ;
Mason, A ;
Floreani, A ;
Heathcote, J ;
Swain, MG ;
Jones, DEJ ;
Lindor, KM ;
Bassendine, MF ;
Worman, HJ .
HEPATOLOGY, 2004, 40 (04) :1013-1020
[9]
THE PRURITUS OF CHOLESTASIS - POTENTIAL PATHOGENIC AND THERAPEUTIC IMPLICATIONS OF OPIOIDS [J].
BERGASA, NV ;
JONES, EA .
GASTROENTEROLOGY, 1995, 108 (05) :1582-1588
[10]
Fatigue measurements in patients with primary biliary cirrhosis and the risk of mortality during follow-up [J].
Bjornsson, Einar ;
Kalaitzakis, Evangelos ;
Neuhauser, Matthias ;
Enders, Felicity ;
Maetzel, Hardy ;
Chapman, Roger W. ;
Talwalkar, Jayant ;
Lindor, Keith ;
Jorgensen, Roberta .
LIVER INTERNATIONAL, 2010, 30 (02) :251-258